Volume 69 Number 5 October 2002	back to contents

Choriocarcinoma in a Patient with Human Immunodeficiency Virus: Case Presentation and Review of the Literature	334-337
Ida Ashley, M.D.

From the Department of Medicine, Mount Sinai Services at Queens Hospital Center, Jamaica,
NY, and the Mount Sinai School of Medicine, New York, NY.

Address correspondence to Ida Ashley, M.D. Division of Hematology-Oncology, Department of Medicine, Queens Hospital Center, 82-68 164th Street, Jamaica, NY 11432.

Accepted for publication April 1, 2002.

ABSTRACT

A 26-year-old woman with choriocarcinoma and acquired immunodeficiency syndrome initially presented with hydatidiform mole and was treated with dilation and curettage. Because of persistent elevation of serum ß human chorionic gonadotropin, the patient was treated with combination chemotherapy with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMACO) for high-risk gestational trophoblastic tumor. The patient’s initial stage was IIc. The serum ß human chorionic gonadotropin level returned to normal. Fourteen months later, the gonadotropin level again increased. The patient was treated with uterine curettage followed by vaginal hysterectomy. Despite further chemotherapy (with methotrexate and leucovorin, then oral etoposide), she died following metastasis of the tumor to the brain.

Only four other cases of human immunodeficiency virus (HIV) infection with choriocarcinoma have been reported. There is no evidence to date that gestational trophoblastic disease is more prevalent in patients with acquired immunodeficiency syndrome. HIV infection and other immunodeficiency states, however, can influence the course of treatment and outcome in these patients. The low CD4 count in HIV infection may lead to a poor outcome despite chemotherapy.

KEYWORDS

Choriocarcinoma, acquired immunodeficiency syndrome, HIV.

MSSM Home

Back Issues | Indexes | Search | Journal Home